Xcell Therapeutics

Company Profile

Sector

Healthcare

Industry

Biotechnology

Employees

N/A

Website

xcell.co.kr/kor/

Country

South Korea

Exchange

KOSDAQ

Founded 2015

Xcell Therapeutics provides the development and production of drugs for cell therapy. It offers CellCor, a serum-free chemically defined medium that is used to develop human mesenchymal stem cells XPorT, a platform that aims to develop optimal media from the perspective of the user using a variety of cells.

Additionally, it develops media for cell culture in various areas of the bioindustry such as cell therapy, gene therapy, exosomes, organoids and bioreactors. Founded in 2015, Xcell Therapeutics is based in Seoul, South Korea.

Key Stats

52-Week Range

₩1090.00₩4075.00

Beta1.30

Trailing P/EN/A

Forward P/EN/A

Trailing EPSN/A

Avg Volume

Earnings & Analyst

Next EarningsN/A

EPS EstimateN/A

Target Mean PriceN/A

RecommendationNone

Recommendation MeanN/A

Recent SEC Filings

SEC filings for this ticker are not available yet.